Cardiomyopathies--misdiagnosed as Sudden Infant Death Syndrome (SIDS)

Area of Science:

• Cardiology
• Genetics
• Pathology

Background:

• Cardiomyopathies represent a diverse group of cardiac diseases with evolving definitions.
• Molecular genetics has rapidly advanced the field of cardiology over the past decade.

Observation:

• New disease entities and improved diagnostic capabilities have emerged.
• Myocardial diseases like Hypertrophic Cardiomyopathy (HCM) and Arrhythmogenic Right Ventricular Cardiomyopathy (ARVCM), along with channelopathies such as Long QT Syndrome (LQTS), Brugada Syndrome (BrS), Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), and Short QT Syndrome (SQTS), are recognized as predisposing factors for potentially lethal ventricular tachyarrhythmias.

Findings:

• Genetic mutations are increasingly identified as causative factors.
• Histological and immunohistochemical analyses of myocardial tissue can indicate underlying cardiomyopathies.
• Microscopic examination of the myocardium can guide genetic mutation searches in cases of suspected Sudden Infant Death Syndrome (SIDS).

Implications:

• Updated disease definitions are necessary due to recent scientific progress.
• Genetic testing and histological analysis are crucial for diagnosing cardiomyopathies and channelopathies.
• These diagnostic approaches can provide etiological explanations for sudden, unexpected deaths, particularly in infants.